Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
Memgen, Inc.
DEKA Biosciences
Purple Biotech Ltd.
Eli Lilly and Company
Fate Therapeutics